Cambridge Investment Research Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-7,504
Closed -$932K 3695
2025
Q1
$932K Buy
7,504
+2,067
+38% +$257K ﹤0.01% 1924
2024
Q4
$670K Sell
5,437
-778
-13% -$95.9K ﹤0.01% 2190
2024
Q3
$692K Buy
6,215
+189
+3% +$21K ﹤0.01% 2147
2024
Q2
$643K Buy
+6,026
New +$643K ﹤0.01% 2094
2023
Q4
Sell
-1,941
Closed -$251K 3250
2023
Q3
$251K Sell
1,941
-457
-19% -$59.1K ﹤0.01% 2636
2023
Q2
$297K Buy
2,398
+96
+4% +$11.9K ﹤0.01% 2529
2023
Q1
$337K Sell
2,302
-2,480
-52% -$363K ﹤0.01% 2388
2022
Q4
$762K Buy
4,782
+1,088
+29% +$173K ﹤0.01% 1701
2022
Q3
$492K Buy
3,694
+34
+0.9% +$4.53K ﹤0.01% 1947
2022
Q2
$571K Sell
3,660
-84
-2% -$13.1K ﹤0.01% 1866
2022
Q1
$583K Sell
3,744
-1,226
-25% -$191K ﹤0.01% 1982
2021
Q4
$633K Sell
4,970
-987
-17% -$126K ﹤0.01% 1925
2021
Q3
$776K Buy
5,957
+121
+2% +$15.8K ﹤0.01% 1730
2021
Q2
$1.04M Buy
5,836
+2,587
+80% +$460K 0.01% 1508
2021
Q1
$534K Sell
3,249
-1,734
-35% -$285K ﹤0.01% 1857
2020
Q4
$822K Buy
4,983
+1,790
+56% +$295K ﹤0.01% 1433
2020
Q3
$455K Buy
+3,193
New +$455K ﹤0.01% 1661
2019
Q3
Sell
-2,979
Closed -$425K 2378
2019
Q2
$425K Buy
+2,979
New +$425K ﹤0.01% 1539
2018
Q3
Sell
-1,605
Closed -$277K 2271
2018
Q2
$277K Buy
+1,605
New +$277K ﹤0.01% 1788
2017
Q3
Sell
-1,462
Closed -$227K 2032
2017
Q2
$227K Buy
+1,462
New +$227K ﹤0.01% 1672
2016
Q1
Sell
-1,498
Closed -$211K 1630
2015
Q4
$211K Sell
1,498
-40
-3% -$5.63K 0.01% 1335
2015
Q3
$204K Sell
1,538
-630
-29% -$83.6K 0.01% 1249
2015
Q2
$382K Sell
2,168
-539
-20% -$95K 0.01% 942
2015
Q1
$468K Buy
2,707
+137
+5% +$23.7K 0.01% 834
2014
Q4
$421K Buy
2,570
+440
+21% +$72.1K 0.01% 864
2014
Q3
$342K Sell
2,130
-420
-16% -$67.4K 0.01% 1026
2014
Q2
$375K Buy
2,550
+286
+13% +$42.1K 0.01% 893
2014
Q1
$314K Sell
2,264
-3,642
-62% -$505K 0.01% 936
2013
Q4
$747K Sell
5,906
-3,069
-34% -$388K 0.03% 484
2013
Q3
$825K Buy
+8,975
New +$825K 0.04% 429